title: Morbidity and quality of life following cytoreduction and HIPEC.
authors.affiliation: Department of Surgery, National Cancer Institute, Milano, Italy. marcello.deraco@istitutotumori.mi.it
authors.forename: M
authors.initials: M
authors.lastname: Deraco
authors.forename: D
authors.initials: D
authors.lastname: Baratti
authors.forename: S
authors.initials: S
authors.lastname: Kusamura
mesh_terms: D002277:Carcinoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007263:Infusions, Parenteral; D007410:Intestinal Diseases / Q000175:diagnosis; D008297:Male; D019060:Minimally Invasive Surgical Procedures; D009017:Morbidity; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011183:Postoperative Complications; D011788:Quality of Life; D016019:Survival Analysis